Lexaria Bioscience Corp. (LEXX)
0.65
+0.04
(+7.33%)
USD |
NASDAQ |
May 22, 16:00
0.6451
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Profit Margin (Quarterly) : -7.26K% for Feb. 28, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -60.88% |
| InMed Pharmaceuticals, Inc. | -- |
| Target Group, Inc. (Canada) | -61.69% |
| Tilray Brands, Inc. | -12.21% |
| NervGen Pharma Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -188.8% |
| Return on Assets | -148.4% |
| Return on Invested Capital | -184.8% |
| Gross Profit Margin (Quarterly) | -33.00% |
| Operating Margin (Quarterly) | -7.26K% |
| Return on Net Operating Assets | -611.8% |